Hydra Biosciences

Hydra Biosciences, biopharmaceutical company, Cambridge, Massachusetts, novel drugs important human diseases, major therapeutic areas, pain, cardiovascular disease, transient receptor potential (TRP) ion channels, molecular regeneration..

Launch date

2001

Employees

2-10 people

Market cap

Enterprise valuation

Cambridge Massachusetts (HQ)

http://hydrabiosciences.com

https://twitter.com/hydrabio https://www.linkedin.com/company/hydra-biosciences

Date	Investors	Amount	Round
-	Acceleration International	N/A	-
Dec 2001	N/A	$200k	Seed
Jul 2002	Polaris Partners New Enterprise Associates Abingworth Advanced Technology Ventures	$9.3m	Series A
Jan 2004	Polaris Partners New Enterprise Associates Lilly Ventures Bioventures Investors Advanced Technology Ventures Abbott	$18.9m	Series B
Mar 2008	Polaris Partners New Enterprise Associates Lilly Ventures Bioventures Investors Advanced Technology Ventures	$34.0m	Series C
Jan 2009	MedImmune Ventures	$22.0m	Series D
Mar 2015	Lilly Ventures	$10.5m	Series E
Total Funding		CAD129m

Tech stackLearn more about the technologies and tools that this company uses.

Hydra Biosciences

Hydra Biosciences

Related Content

Recent News about Hydra Biosciences

Tech stack